FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to biotechnology and immunology. What is presented is an isolated monoclonal antibody or its immunoreactive fragment binding to the respiratory syncytial virus (RSV) G protein epitope of the strain A2. There are also described a nucleic acid molecule coding it, a host cell containing this nucleic acid molecule, a method for producing the antibody and a pharmaceutical composition containing this antibody.
EFFECT: presented group of inventions can be used for treating respiratory syncytial virus.
14 cl, 37 dwg, 1 tbl, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| HIGH-AFFINITY HUMAN ANTIBODIES TO CYTOMEGALOVIRUS (CMV) gB PROTEIN | 2011 |
|
RU2613421C2 |
| ANTIBODIES USED PASSIVE VACCINATION AGAINST INFLUENZA | 2012 |
|
RU2668802C2 |
| METHODS OF COMBINED THERAPY USING BINDING MATERIALS WITH PSL AND PCRV PSEUDOMONAS | 2012 |
|
RU2687588C2 |
| ANTIBODIES SUITABLE FOR PASSIVE IMMUNIZATION AGAINST INFLUENZA | 2011 |
|
RU2635999C2 |
| MOLECULES WHICH BIND TO PSL PSEUDOMONAS, AND METHODS FOR USE THEREOF | 2012 |
|
RU2708977C2 |
| RSV-SPECIFIC ANTIBODIES AND THEIR FUNCTIONAL PARTS | 2015 |
|
RU2785598C2 |
| RSV-SPECIFIC BINDING MOLECULES AND MEANS FOR OBTAINING THEM | 2008 |
|
RU2527067C2 |
| ANTIBODIES FOR SPECIFIC BINDING OF STAPHYLOCOCCUS AUREUS ALPHA-TOXIN AND METHODS OF APPLICATION | 2012 |
|
RU2620065C2 |
| RSV-SPECIFIC BINDING MOLECULES AND MEANS FOR THEIR OBTAINING | 2008 |
|
RU2628095C2 |
| MONOCLONAL ANTIBODY ABLE TO BIND TO SPECIFIC DISCONTINUOUS EPITOPE PLACED IN AD1 REGION OF HUMAN CYTOMEGALOVIRUS GB GLYCOPROTEIN, AND ITS ANTIGEN-BINDING FRAGMENT | 2010 |
|
RU2542472C2 |
